Abstract
Inflammation and autoimmune disorders have received much greater attention in the recent years due to the elucidation of various molecular mechanisms and the discoveries of various cytokines and other proteins involved in these processes. These discoveries are helping develop novel therapeutics including small molecules and protein therapeutics (biologics) for the treatment of sterile and nonsterile inflammatory disorders. Small molecule drugs have several advantages over protein therapeutics including their affordability for chronic treatments. In this review article, recent successes targeting various inflammatory cytokines and the corresponding receptors such as TLRs, interleukins, p38α as well as recent strategies for developing small molecule antagonists using rational models are discussed.
Keywords: Inflammation, Cytokines, Small molecule targets, Toll-like receptors, p38α kinase, Interferon, autoimmune disorders, pathogens, macrophages, fibrosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Immunological Targets in Inflammation from the Small Molecule Perspective
Volume: 10 Issue: 2
Author(s): Angelica M. Bello, Meena K. Purohit, Tracy Jun Yang Cui, Slater Brandon Stead and Lakshmi P. Kotra
Affiliation:
Keywords: Inflammation, Cytokines, Small molecule targets, Toll-like receptors, p38α kinase, Interferon, autoimmune disorders, pathogens, macrophages, fibrosis
Abstract: Inflammation and autoimmune disorders have received much greater attention in the recent years due to the elucidation of various molecular mechanisms and the discoveries of various cytokines and other proteins involved in these processes. These discoveries are helping develop novel therapeutics including small molecules and protein therapeutics (biologics) for the treatment of sterile and nonsterile inflammatory disorders. Small molecule drugs have several advantages over protein therapeutics including their affordability for chronic treatments. In this review article, recent successes targeting various inflammatory cytokines and the corresponding receptors such as TLRs, interleukins, p38α as well as recent strategies for developing small molecule antagonists using rational models are discussed.
Export Options
About this article
Cite this article as:
M. Bello Angelica, K. Purohit Meena, Jun Yang Cui Tracy, Brandon Stead Slater and P. Kotra Lakshmi, Immunological Targets in Inflammation from the Small Molecule Perspective, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2011; 10 (2) . https://dx.doi.org/10.2174/1871523011107020121
DOI https://dx.doi.org/10.2174/1871523011107020121 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis and Anti-HIV-Evaluation of Novel Andrographolide Derivatives
Letters in Drug Design & Discovery Nuclear Translocation of Heme Oxygenase-1 Confers Resistance to Imatinib in Chronic Myeloid Leukemia Cells
Current Pharmaceutical Design Immunomodulation Via Targeted Inhibition of Antigen Receptor Signal Transduction
Cardiovascular & Hematological Disorders-Drug Targets Efficacy and Safety of Sleeping Beauty Transposon-Mediated Gene Transfer in Preclinical Animal Studies
Current Gene Therapy Defective and Excessive Immunities in Pediatric Diseases
Current Pharmaceutical Design CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies
Current Cancer Drug Targets (Neuro)Transmitter Systems in Circulating Immune Cells: A Target of Immunopharmacological Interventions?
Current Medicinal Chemistry Editorial (Hot Topic:Aspergillosis: New Insights into Disease, Diagnostic and Treatment)
Current Pharmaceutical Design Immature DC Isolated After Co-Culture with PUVA-Treated Peripheral Blood Mononuclear Cells Downregulate Graft-Versus-Host Reactions in the Human Skin Explant Model
Current Stem Cell Research & Therapy Current Therapeutic Approaches in Inflammatory Bowel Disease
Current Pharmaceutical Design Computational Tools in the Discovery of New G-Quadruplex Ligands with Potential Anticancer Activity
Current Topics in Medicinal Chemistry MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases
Current Pharmaceutical Design Evaluation of Drug Targeting Strategies and Liposomal Trafficking
Current Pharmaceutical Design Exploring Old Drugs for the Treatment of Hematological Malignancies
Current Medicinal Chemistry Mast Cells in Lung Homeostasis: Beyond Type I Hypersensitivity
Current Respiratory Medicine Reviews FOXO and FOXM1 in Cancer: The FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy
Current Drug Targets Pharmacological Activity of Natural Non-glycosylated Triterpenes
Mini-Reviews in Organic Chemistry Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Current Drug Metabolism Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways
Current Pharmaceutical Design Targeted Tumor Therapies at a Glance
Current Drug Targets